PLN 7.89
(6.91%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 4.45 Million PLN | 16.8% |
2022 | 3.81 Million PLN | 9.55% |
2021 | 3.47 Million PLN | 100.12% |
2020 | 1.73 Million PLN | -3.52% |
2019 | 1.8 Million PLN | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 8.49 Million PLN | 90.88% |
2024 Q2 | 12.09 Million PLN | 42.42% |
2023 FY | 4.45 Million PLN | 16.8% |
2023 Q4 | 4.45 Million PLN | 22.02% |
2023 Q3 | 3.64 Million PLN | -56.94% |
2023 Q2 | 8.47 Million PLN | 105.18% |
2023 Q1 | 4.12 Million PLN | 8.35% |
2022 Q2 | 2.99 Million PLN | -44.36% |
2022 Q4 | 3.81 Million PLN | 31.88% |
2022 Q1 | 5.38 Million PLN | 27.94% |
2022 Q3 | 2.88 Million PLN | -3.54% |
2021 Q2 | 2.06 Million PLN | 0.0% |
2021 Q4 | 4.2 Million PLN | 73.9% |
2021 Q3 | 2.41 Million PLN | 17.26% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Adiuvo Investments S.A. | 45.77 Million PLN | 90.279% |
Medinice S.A. | 1.51 Million PLN | -193.923% |
Medicalgorithmics S.A. | 29.06 Million PLN | 84.689% |
Synektik Spólka Akcyjna | 146.03 Million PLN | 96.953% |